dsp 4 has been researched along with beta-funaltrexamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T; Takahashi, Y; Takamori, K | 1 |
| Choi, SS; Han, EJ; Han, KJ; Lee, HK; Suh, HW | 1 |
2 other study(ies) available for dsp 4 and beta-funaltrexamine
| Article | Year |
|---|---|
Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzylamines; Dopamine; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sympathomimetics | 1993 |
Possible antinociceptive mechanisms of opioid receptor antagonists in the mouse formalin test.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Benzylamines; Formaldehyde; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Pain Measurement; Receptors, Opioid, delta; Receptors, Opioid, mu | 2003 |